Zsweet(TM), 100% All Natural, Zero Calorie Sweetener, Shows No Impact on Blood Sugar

Zsweet(TM), 100% All Natural, Zero Calorie Sweetener, Shows No Impact on Blood Sugar Company has announced completion of a clinical study to determine the ultra-low glycemic response in humans on Zsweet(TM), patent-pending sweetener. Study indicated that consuming 15 grams (3 tsp.) of Zsweet(TM), on average, did not raise or lower blood glucose levels in healthy individuals
Home Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P. Natrol Appoints Vincent Andrich VP Sales for Prolab Division Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results Body Shop Reports 24.8 Mil Euro Sales Revenues Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label Supplement Group Targets Consumer Education Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO drugstore.com Expects to Reach Profitability Target in 2003 Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway Natural Health Trends Corp. Launches Lexxus Taiwan FDA Presents Compliance Guide for Structure/Function Claims New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids Cyanotech Names Bob Capelli as Director of Sales Research Finds Flavanols in Cocoa May Help Treat Diabetes, Strokes and Dementia Mars scientists have discovered that entire "libraries" of cocoa flavanols can be synthesized, and that new flavanols can be developed from natural flavanols. Research Finds Flavanols in Cocoa May Help Treat Diabetes, Strokes and Dementia Mars scientists have discovered that entire "libraries" of cocoa flavanols can be synthesized, and that new flavanols can be developed from natural flavanols. Research Finds Flavanols in Cocoa May Help Treat Diabetes, Strokes and Dementia Mars scientists have discovered that entire "libraries" of cocoa flavanols can be synthesized, and that new flavanols can be developed from natural flavanols. Study Confirms Cinnulin PF Effectively Increases Insulin Sensitivity in Pre-Diabetes Sufferers placebo-controlled, double-blind study conducted by the Ohio Research Group examined the effect of supplementation with Cinnulin PF on blood glucose regulation, lipid profiles and body composition in pre-diabetic men and women, indicating that subjects in the Cinnulin PF group noted statistically significant decreases in fasting blood glucose levels, marked improvements in insulin sensitivity. Study Confirms Cinnulin PF Effectively Increases Insulin Sensitivity in Pre-Diabetes Sufferers placebo-controlled, double-blind study conducted by the Ohio Research Group examined the effect of supplementation with Cinnulin PF on blood glucose regulation, lipid profiles and body composition in pre-diabetic men and women, indicating that subjects in the Cinnulin PF group noted statistically significant decreases in fasting blood glucose levels, marked improvements in insulin sensitivity. Study Confirms Cinnulin PF Effectively Increases Insulin Sensitivity in Pre-Diabetes Sufferers placebo-controlled, double-blind study conducted by the Ohio Research Group examined the effect of supplementation with Cinnulin PF on blood glucose regulation, lipid profiles and body composition in pre-diabetic men and women, indicating that subjects in the Cinnulin PF group noted statistically significant decreases in fasting blood glucose levels, marked improvements in insulin sensitivity. Study Confirms Cinnulin PF Effectively Increases Insulin Sensitivity in Pre-Diabetes Sufferers placebo-controlled, double-blind study conducted by the Ohio Research Group examined the effect of supplementation with Cinnulin PF on blood glucose regulation, lipid profiles and body composition in pre-diabetic men and women, indicating that subjects in the Cinnulin PF group noted statistically significant decreases in fasting blood glucose levels, marked improvements in insulin sensitivity. Study Confirms Cinnulin PF Effectively Increases Insulin Sensitivity in Pre-Diabetes Sufferers placebo-controlled, double-blind study conducted by the Ohio Research Group examined the effect of supplementation with Cinnulin PF on blood glucose regulation, lipid profiles and body composition in pre-diabetic men and women, indicating that subjects in the Cinnulin PF group noted statistically significant decreases in fasting blood glucose levels, marked improvements in insulin sensitivity. New Study Suggests that Supplementation with L-Carnipure® Tartrate During Pregnancy Can Reduce Increased Levels of Plasma Free Fatty Acids, a Major Factor in Gestational Diabetes Company-supported study, conducted at the University of Vienna (Austria), published in Chemical Monthly, observes that supplementation with L-Carnipure® tartrate during pregnancy can significantly reduce the increased level of plasma free fatty acids, considered the main cause of insulin resistance, a major factor in gestational diabetes in pregnant women. New Study Suggests that Supplementation with L-Carnipure® Tartrate During Pregnancy Can Reduce Increased Levels of Plasma Free Fatty Acids, a Major Factor in Gestational Diabetes Company-supported study, conducted at the University of Vienna (Austria), published in Chemical Monthly, observes that supplementation with L-Carnipure® tartrate during pregnancy can significantly reduce the increased level of plasma free fatty acids, considered the main cause of insulin resistance, a major factor in gestational diabetes in pregnant women. New Study Suggests that Supplementation with L-Carnipure® Tartrate During Pregnancy Can Reduce Increased Levels of Plasma Free Fatty Acids, a Major Factor in Gestational Diabetes Company-supported study, conducted at the University of Vienna (Austria), published in Chemical Monthly, observes that supplementation with L-Carnipure® tartrate during pregnancy can significantly reduce the increased level of plasma free fatty acids, considered the main cause of insulin resistance, a major factor in gestational diabetes in pregnant women. New Study Suggests that Supplementation with L-Carnipure® Tartrate During Pregnancy Can Reduce Increased Levels of Plasma Free Fatty Acids, a Major Factor in Gestational Diabetes Company-supported study, conducted at the University of Vienna (Austria), published in Chemical Monthly, observes that supplementation with L-Carnipure® tartrate during pregnancy can significantly reduce the increased level of plasma free fatty acids, considered the main cause of insulin resistance, a major factor in gestational diabetes in pregnant women. New Study Suggests that Supplementation with L-Carnipure® Tartrate During Pregnancy Can Reduce Increased Levels of Plasma Free Fatty Acids, a Major Factor in Gestational Diabetes Company-supported study, conducted at the University of Vienna (Austria), published in Chemical Monthly, observes that supplementation with L-Carnipure® tartrate during pregnancy can significantly reduce the increased level of plasma free fatty acids, considered the main cause of insulin resistance, a major factor in gestational diabetes in pregnant women. Study: Chromium Picolinate May Provide Cardiovascular Benefits in Pre-Diabetes Preclinical study on rats, conducted at the University of Alberta, and presented at the 3rd World Congress on Insulin Resistance Syndrome, shows daily use of chromium picolinate provides significant cardiovascular benefits in pre-diabetic rats that have insulin resistance Study: Chromium Picolinate May Provide Cardiovascular Benefits in Pre-Diabetes Preclinical study on rats, conducted at the University of Alberta, and presented at the 3rd World Congress on Insulin Resistance Syndrome, shows daily use of chromium picolinate provides significant cardiovascular benefits in pre-diabetic rats that have insulin resistance Study: Chromium Picolinate May Provide Cardiovascular Benefits in Pre-Diabetes Preclinical study on rats, conducted at the University of Alberta, and presented at the 3rd World Congress on Insulin Resistance Syndrome, shows daily use of chromium picolinate provides significant cardiovascular benefits in pre-diabetic rats that have insulin resistance Study: Chromium Picolinate May Provide Cardiovascular Benefits in Pre-Diabetes Preclinical study on rats, conducted at the University of Alberta, and presented at the 3rd World Congress on Insulin Resistance Syndrome, shows daily use of chromium picolinate provides significant cardiovascular benefits in pre-diabetic rats that have insulin resistance Study: Chromium Picolinate May Provide Cardiovascular Benefits in Pre-Diabetes Preclinical study on rats, conducted at the University of Alberta, and presented at the 3rd World Congress on Insulin Resistance Syndrome, shows daily use of chromium picolinate provides significant cardiovascular benefits in pre-diabetic rats that have insulin resistance Study: Chromium Picolinate May Provide Cardiovascular Benefits in Pre-Diabetes Preclinical study on rats, conducted at the University of Alberta, and presented at the 3rd World Congress on Insulin Resistance Syndrome, shows daily use of chromium picolinate provides significant cardiovascular benefits in pre-diabetic rats that have insulin resistance Study: Chromium Picolinate Helps Muscles Use Blood Sugar - Prompts Insulin to Work Better Study published in February's Journal of Nutrition reports that daily use of chromium picolinate enhanced muscle sensitivity to insulin in obese, insulin-resistant rats. Study: Chromium Picolinate Helps Muscles Use Blood Sugar - Prompts Insulin to Work Better Study published in February's Journal of Nutrition reports that daily use of chromium picolinate enhanced muscle sensitivity to insulin in obese, insulin-resistant rats. Study: Chromium Picolinate Helps Muscles Use Blood Sugar - Prompts Insulin to Work Better Study published in February's Journal of Nutrition reports that daily use of chromium picolinate enhanced muscle sensitivity to insulin in obese, insulin-resistant rats. New Study Shows Cinnamon Lowers Blood Pressure and Improves Insulin Function Placebo-controlled, double-blind study from Georgetown University in this month’s Journal of the American College of Nutrition indicates that rats taking whole cinnamon or cinnamon extract showed decreased systolic blood pressure and improved insulin function, with the extract group lowering circulating levels of fructosamine and the whole cinnamon group lowering circulating insulin concentrations. New Study Shows Cinnamon Lowers Blood Pressure and Improves Insulin Function Placebo-controlled, double-blind study from Georgetown University in this month’s Journal of the American College of Nutrition indicates that rats taking whole cinnamon or cinnamon extract showed decreased systolic blood pressure and improved insulin function, with the extract group lowering circulating levels of fructosamine and the whole cinnamon group lowering circulating insulin concentrations. New Study Shows Cinnamon Lowers Blood Pressure and Improves Insulin Function Placebo-controlled, double-blind study from Georgetown University in this month’s Journal of the American College of Nutrition indicates that rats taking whole cinnamon or cinnamon extract showed decreased systolic blood pressure and improved insulin function, with the extract group lowering circulating levels of fructosamine and the whole cinnamon group lowering circulating insulin concentrations. New Study Shows Cinnamon Lowers Blood Pressure and Improves Insulin Function Placebo-controlled, double-blind study from Georgetown University in this month’s Journal of the American College of Nutrition indicates that rats taking whole cinnamon or cinnamon extract showed decreased systolic blood pressure and improved insulin function, with the extract group lowering circulating levels of fructosamine and the whole cinnamon group lowering circulating insulin concentrations. New Study Shows Cinnamon Lowers Blood Pressure and Improves Insulin Function Placebo-controlled, double-blind study from Georgetown University in this month’s Journal of the American College of Nutrition indicates that rats taking whole cinnamon or cinnamon extract showed decreased systolic blood pressure and improved insulin function, with the extract group lowering circulating levels of fructosamine and the whole cinnamon group lowering circulating insulin concentrations. Herbal Remedy Could Help Sufferers of Type 2 Diabetes British researchers, in a placebo controlled study on 79 subjects, set out to see if patients with type 2 diabetes, consuming a western diet and taking prescribed medication with daily hawthorn extract would show greater hypotensive effects over 16 weeks than a placebo group. The researhcers observed that those taking the hawthorn, after a 16 week period, had a significant reduction of 2.6 mmHg in their diastolic blood pressure. Herbal Remedy Could Help Sufferers of Type 2 Diabetes British researchers, in a placebo controlled study on 79 subjects, set out to see if patients with type 2 diabetes, consuming a western diet and taking prescribed medication with daily hawthorn extract would show greater hypotensive effects over 16 weeks than a placebo group. The researhcers observed that those taking the hawthorn, after a 16 week period, had a significant reduction of 2.6 mmHg in their diastolic blood pressure. Herbal Remedy Could Help Sufferers of Type 2 Diabetes British researchers, in a placebo controlled study on 79 subjects, set out to see if patients with type 2 diabetes, consuming a western diet and taking prescribed medication with daily hawthorn extract would show greater hypotensive effects over 16 weeks than a placebo group. The researhcers observed that those taking the hawthorn, after a 16 week period, had a significant reduction of 2.6 mmHg in their diastolic blood pressure. Herbal Remedy Could Help Sufferers of Type 2 Diabetes British researchers, in a placebo controlled study on 79 subjects, set out to see if patients with type 2 diabetes, consuming a western diet and taking prescribed medication with daily hawthorn extract would show greater hypotensive effects over 16 weeks than a placebo group. The researhcers observed that those taking the hawthorn, after a 16 week period, had a significant reduction of 2.6 mmHg in their diastolic blood pressure. Herbal Remedy Could Help Sufferers of Type 2 Diabetes British researchers, in a placebo controlled study on 79 subjects, set out to see if patients with type 2 diabetes, consuming a western diet and taking prescribed medication with daily hawthorn extract would show greater hypotensive effects over 16 weeks than a placebo group. The researhcers observed that those taking the hawthorn, after a 16 week period, had a significant reduction of 2.6 mmHg in their diastolic blood pressure. Herbal Remedy Could Help Sufferers of Type 2 Diabetes British researchers, in a placebo controlled study on 79 subjects, set out to see if patients with type 2 diabetes, consuming a western diet and taking prescribed medication with daily hawthorn extract would show greater hypotensive effects over 16 weeks than a placebo group. The researhcers observed that those taking the hawthorn, after a 16 week period, had a significant reduction of 2.6 mmHg in their diastolic blood pressure. Herbal Remedy Could Help Sufferers of Type 2 Diabetes British researchers, in a placebo controlled study on 79 subjects, set out to see if patients with type 2 diabetes, consuming a western diet and taking prescribed medication with daily hawthorn extract would show greater hypotensive effects over 16 weeks than a placebo group. The researhcers observed that those taking the hawthorn, after a 16 week period, had a significant reduction of 2.6 mmHg in their diastolic blood pressure. Herbal Remedy Could Help Sufferers of Type 2 Diabetes British researchers, in a placebo controlled study on 79 subjects, set out to see if patients with type 2 diabetes, consuming a western diet and taking prescribed medication with daily hawthorn extract would show greater hypotensive effects over 16 weeks than a placebo group. The researhcers observed that those taking the hawthorn, after a 16 week period, had a significant reduction of 2.6 mmHg in their diastolic blood pressure. New Clinical Trial Demonstrates Diachrome(R) Safely Lowers Blood Sugar Levels in People with Type 2 Diabetes Study, presented at the American Diabetes Association (ADA) 66th Annual Scientific Sessions, describes an open-label extension phase to the previously reported 90-day, randomized, double-blind, placebo-controlled, multi-center study that evaluated 368 subjects taking daily Diachrome supplementation, (which showed a 0.53% average drop in HbA1c), noting a further average decrease of 0.96% HbA1c in the longer term study. New Clinical Trial Demonstrates Diachrome(R) Safely Lowers Blood Sugar Levels in People with Type 2 Diabetes Study, presented at the American Diabetes Association (ADA) 66th Annual Scientific Sessions, describes an open-label extension phase to the previously reported 90-day, randomized, double-blind, placebo-controlled, multi-center study that evaluated 368 subjects taking daily Diachrome supplementation, (which showed a 0.53% average drop in HbA1c), noting a further average decrease of 0.96% HbA1c in the longer term study. New Clinical Trial Demonstrates Diachrome(R) Safely Lowers Blood Sugar Levels in People with Type 2 Diabetes Study, presented at the American Diabetes Association (ADA) 66th Annual Scientific Sessions, describes an open-label extension phase to the previously reported 90-day, randomized, double-blind, placebo-controlled, multi-center study that evaluated 368 subjects taking daily Diachrome supplementation, (which showed a 0.53% average drop in HbA1c), noting a further average decrease of 0.96% HbA1c in the longer term study. Clinical study on Cargill’s Barliv(TM) Barley Beta-Glucan to be presented at American Diabetes Association’s 66th Scientific Sessions Double blind study results, presented at the American Diabetes Association’s 66th Scientific Sessions, indicate that adding barley beta-glucan to the diet can significantly improve multiple CVD risk markers, and after-meal metabolism among individuals with the metabolic syndrome. Clinical study on Cargill’s Barliv(TM) Barley Beta-Glucan to be presented at American Diabetes Association’s 66th Scientific Sessions Double blind study results, presented at the American Diabetes Association’s 66th Scientific Sessions, indicate that adding barley beta-glucan to the diet can significantly improve multiple CVD risk markers, and after-meal metabolism among individuals with the metabolic syndrome. Clinical study on Cargill’s Barliv(TM) Barley Beta-Glucan to be presented at American Diabetes Association’s 66th Scientific Sessions Double blind study results, presented at the American Diabetes Association’s 66th Scientific Sessions, indicate that adding barley beta-glucan to the diet can significantly improve multiple CVD risk markers, and after-meal metabolism among individuals with the metabolic syndrome. New Study Shows Cinnamon Extract Lowers Blood Sugar Levels in People with Type 2 Diabetes Placebo-controlled, double-blind study from the University of Hannover in Hannover, Germany published in a recent issue of the European Journal of Clinical Investigation, evaluated the effect of a water-soluble cinnamon extract on glycemic control and the lipid profile of Western patients with type 2 diabetes. New Study Shows Cinnamon Extract Lowers Blood Sugar Levels in People with Type 2 Diabetes Placebo-controlled, double-blind study from the University of Hannover in Hannover, Germany published in a recent issue of the European Journal of Clinical Investigation, evaluated the effect of a water-soluble cinnamon extract on glycemic control and the lipid profile of Western patients with type 2 diabetes. New Study Shows Cinnamon Extract Lowers Blood Sugar Levels in People with Type 2 Diabetes Placebo-controlled, double-blind study from the University of Hannover in Hannover, Germany published in a recent issue of the European Journal of Clinical Investigation, evaluated the effect of a water-soluble cinnamon extract on glycemic control and the lipid profile of Western patients with type 2 diabetes. Compound in dairy products targets diabetes According to a researcher at Penn State, fatty acids commonly found in dairy products, known as conjugated linoleic acids (CLA), ave successfully treated diabetes in mice and have also shown promising results in human trials. Compound in dairy products targets diabetes According to a researcher at Penn State, fatty acids commonly found in dairy products, known as conjugated linoleic acids (CLA), ave successfully treated diabetes in mice and have also shown promising results in human trials. Compound in dairy products targets diabetes According to a researcher at Penn State, fatty acids commonly found in dairy products, known as conjugated linoleic acids (CLA), ave successfully treated diabetes in mice and have also shown promising results in human trials. Compound in dairy products targets diabetes According to a researcher at Penn State, fatty acids commonly found in dairy products, known as conjugated linoleic acids (CLA), ave successfully treated diabetes in mice and have also shown promising results in human trials. Compound in dairy products targets diabetes According to a researcher at Penn State, fatty acids commonly found in dairy products, known as conjugated linoleic acids (CLA), ave successfully treated diabetes in mice and have also shown promising results in human trials. New Study Published in Diabetes Care Shows that Supplementation with Chromium Picolinate Significantly Improves Glycemic Control and Attenuates Weight Gain Results from a new study, conducted by researchers at Pennington Biomedical Research Center (PBRC) and the University of Vermont College of Medicine, and published in the August issue of Diabetes Care, in patients with type 2 diabetes demonstrate that daily supplementation with 1000 mcg of chromium as chromium picolinate, in combination with a common oral anti-diabetic medication, improves insulin sensitivity and glucose control better than the oral anti-diabetic agent alone. New Study Published in Diabetes Care Shows that Supplementation with Chromium Picolinate Significantly Improves Glycemic Control and Attenuates Weight Gain Results from a new study, conducted by researchers at Pennington Biomedical Research Center (PBRC) and the University of Vermont College of Medicine, and published in the August issue of Diabetes Care, in patients with type 2 diabetes demonstrate that daily supplementation with 1000 mcg of chromium as chromium picolinate, in combination with a common oral anti-diabetic medication, improves insulin sensitivity and glucose control better than the oral anti-diabetic agent alone. New Study Published in Diabetes Care Shows that Supplementation with Chromium Picolinate Significantly Improves Glycemic Control and Attenuates Weight Gain Results from a new study, conducted by researchers at Pennington Biomedical Research Center (PBRC) and the University of Vermont College of Medicine, and published in the August issue of Diabetes Care, in patients with type 2 diabetes demonstrate that daily supplementation with 1000 mcg of chromium as chromium picolinate, in combination with a common oral anti-diabetic medication, improves insulin sensitivity and glucose control better than the oral anti-diabetic agent alone. New Study Published in Diabetes Care Shows that Supplementation with Chromium Picolinate Significantly Improves Glycemic Control and Attenuates Weight Gain Results from a new study, conducted by researchers at Pennington Biomedical Research Center (PBRC) and the University of Vermont College of Medicine, and published in the August issue of Diabetes Care, in patients with type 2 diabetes demonstrate that daily supplementation with 1000 mcg of chromium as chromium picolinate, in combination with a common oral anti-diabetic medication, improves insulin sensitivity and glucose control better than the oral anti-diabetic agent alone. New Study Published in Diabetes Care Shows that Supplementation with Chromium Picolinate Significantly Improves Glycemic Control and Attenuates Weight Gain Results from a new study, conducted by researchers at Pennington Biomedical Research Center (PBRC) and the University of Vermont College of Medicine, and published in the August issue of Diabetes Care, in patients with type 2 diabetes demonstrate that daily supplementation with 1000 mcg of chromium as chromium picolinate, in combination with a common oral anti-diabetic medication, improves insulin sensitivity and glucose control better than the oral anti-diabetic agent alone. New Study Shows Cinnamon Extract Provides Antioxidant Support for People with Impaired Fasting Blood Sugar Data from placebo-controlled, double blind study, presented at the 47th American College of Nutrition annual meeting indicates that proprietary cinnamon extract may provide protective antioxidant effects in reducing oxidative stress associated with the metabolic syndrome which is associated with early signs of diabetes and cardiovascular diseases. New Study Shows Cinnamon Extract Provides Antioxidant Support for People with Impaired Fasting Blood Sugar Data from placebo-controlled, double blind study, presented at the 47th American College of Nutrition annual meeting indicates that proprietary cinnamon extract may provide protective antioxidant effects in reducing oxidative stress associated with the metabolic syndrome which is associated with early signs of diabetes and cardiovascular diseases. New Study Shows Cinnamon Extract Provides Antioxidant Support for People with Impaired Fasting Blood Sugar Data from placebo-controlled, double blind study, presented at the 47th American College of Nutrition annual meeting indicates that proprietary cinnamon extract may provide protective antioxidant effects in reducing oxidative stress associated with the metabolic syndrome which is associated with early signs of diabetes and cardiovascular diseases. Silymarin may help sugar-control in people with type II diabetes Research published this week in Phytotherapy Research shows that this extract can help people significantly lower the amount of sugar bound to haemoglobin in blood, as well as reducing fasting blood sugar levels. Silymarin may help sugar-control in people with type II diabetes Research published this week in Phytotherapy Research shows that this extract can help people significantly lower the amount of sugar bound to haemoglobin in blood, as well as reducing fasting blood sugar levels. Silymarin may help sugar-control in people with type II diabetes Research published this week in Phytotherapy Research shows that this extract can help people significantly lower the amount of sugar bound to haemoglobin in blood, as well as reducing fasting blood sugar levels. New Published Research Affirms the Benefits of Diachrome(R) for Improving Blood Sugar in People with Type 2 Diabetes results of a recent placebo controlled, double-blind, randomized, single center study, published in the December issue of Diabetes Technology and Therapeutics, indicate that Diachrome(R), a patented combination of chromium picolinate and biotin, safely improves blood glucose levels and cholesterol metabolism in people with type 2 diabetes. New Published Research Affirms the Benefits of Diachrome(R) for Improving Blood Sugar in People with Type 2 Diabetes results of a recent placebo controlled, double-blind, randomized, single center study, published in the December issue of Diabetes Technology and Therapeutics, indicate that Diachrome(R), a patented combination of chromium picolinate and biotin, safely improves blood glucose levels and cholesterol metabolism in people with type 2 diabetes. New Published Research Affirms the Benefits of Diachrome(R) for Improving Blood Sugar in People with Type 2 Diabetes results of a recent placebo controlled, double-blind, randomized, single center study, published in the December issue of Diabetes Technology and Therapeutics, indicate that Diachrome(R), a patented combination of chromium picolinate and biotin, safely improves blood glucose levels and cholesterol metabolism in people with type 2 diabetes. New Published Research Affirms the Benefits of Diachrome(R) for Improving Blood Sugar in People with Type 2 Diabetes results of a recent placebo controlled, double-blind, randomized, single center study, published in the December issue of Diabetes Technology and Therapeutics, indicate that Diachrome(R), a patented combination of chromium picolinate and biotin, safely improves blood glucose levels and cholesterol metabolism in people with type 2 diabetes. New Published Research Affirms the Benefits of Diachrome(R) for Improving Blood Sugar in People with Type 2 Diabetes results of a recent placebo controlled, double-blind, randomized, single center study, published in the December issue of Diabetes Technology and Therapeutics, indicate that Diachrome(R), a patented combination of chromium picolinate and biotin, safely improves blood glucose levels and cholesterol metabolism in people with type 2 diabetes. Review Indicates That Chromium Picolinate Shows Clinical Benefits in Diabetes Management A review of 15 clinical studies of people with diabetes, published in Diabetes Technology & Therapeutics, confirms that chromium picolinate is effective in improving glycemic control and normalizing lipid levels in people with type 2 diabetes. Review Indicates That Chromium Picolinate Shows Clinical Benefits in Diabetes Management A review of 15 clinical studies of people with diabetes, published in Diabetes Technology & Therapeutics, confirms that chromium picolinate is effective in improving glycemic control and normalizing lipid levels in people with type 2 diabetes. Review Indicates That Chromium Picolinate Shows Clinical Benefits in Diabetes Management A review of 15 clinical studies of people with diabetes, published in Diabetes Technology & Therapeutics, confirms that chromium picolinate is effective in improving glycemic control and normalizing lipid levels in people with type 2 diabetes. Review Indicates That Chromium Picolinate Shows Clinical Benefits in Diabetes Management A review of 15 clinical studies of people with diabetes, published in Diabetes Technology & Therapeutics, confirms that chromium picolinate is effective in improving glycemic control and normalizing lipid levels in people with type 2 diabetes. Review Indicates That Chromium Picolinate Shows Clinical Benefits in Diabetes Management A review of 15 clinical studies of people with diabetes, published in Diabetes Technology & Therapeutics, confirms that chromium picolinate is effective in improving glycemic control and normalizing lipid levels in people with type 2 diabetes. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Another Reason to Choose Healthy Lifestyle Habits Another Reason to Choose Healthy Lifestyle Habits	Renowned Research Group Validates Near-Zero Glycemic Effect SAN CLEMENTE, Calif., May 22 /PRNewswire/ -- Ventana Health Inc., makers of Zsweet(TM), a zero calorie, 100% natural sweetener, has announced completion of a clinical study to determine the ultra-low glycemic response in humans on this patent-pending sweetener. The independent study was performed by Toronto based, Glycemic Index Laboratories, Inc. Zsweet(TM) is comprised of erythritol, a naturally-occurring sugar alcohol with exceptional tolerability, and food extracts commonly found in fruits and vegetables as flavor enhancers, all of which are generally recognized as safe for food and beverage use by the FDA. The addition of the natural flavors transforms erythritol into a multi-purpose bulk sweetener with exceptional palatability and no unpleasant aftertaste. "One of the pivotal attributes of Zsweet(TM) is its zero calorie profile," offers Tim Avila, creator of Zsweet(TM) and chief executive officer of Ventana Health Inc. "One additional step we wanted to take was to confirm it had no glycemic impact-no elevation in blood sugar. To perform a meaningful study, we used a test quantity comparable to 4 servings of table sugar. Indeed, the study revealed what we expected." The study examined the glycemic response comparison between Zsweet(TM) and standard white bread. The glycemic index, noted as a fast tracking trend among numerous trend-watching organizations, can be determined for any food, beverage, or sweetener only through performing a clinical study. "The study indicated that consuming 15 grams (3 tsp.) of Zsweet(TM), on average, did not raise or lower blood glucose levels in healthy individuals," says Dr. Vladimir Vuksan, PhD and vice president of Glycemic Index Laboratories, Inc. Zsweet(TM) was launched for consumer use in January 2006 and was recently exhibited at the 2006 Natural Products Expo West Trade Show in Anaheim, California. Results of this study will be revealed at various scientific meetings later this year. In addition, Ventana Health Inc. will continue to produce various research studies that will reveal the benefits related to Zsweet(TM). For more information on the results, Zsweet(TM) and/or Ventana Health Inc., please contact Lucila Garcia at 949-369-6515 or lucila@ventanalife.com About Ventana Health Inc. The Ventana Health mission is inspired by consumer demand worldwide to find and adopt intelligent food alternatives of the highest integrity and quality that tastes good and is healthy for you. The cornerstone message of the Ventana Health products is built on education as to the options regarding healthy living alternatives and food choices. About Glycemic Index Laboratories Inc. Glycemic Index Laboratories Inc. is the only laboratory licensed to use patented methodology that has been scientifically shown to improve precision and consistency of metabolic responses to carbohydrate foods. The directors of GI Labs were on the original research team that developed the glycemic index in the 1980's.
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software